You are here:
Publication details
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
Authors | |
---|---|
Year of publication | 2023 |
Type | Article in Periodical |
Magazine / Source | Annals of hematology |
MU Faculty or unit | |
Citation | |
web | https://link.springer.com/article/10.1007/s00277-023-05479-w |
Doi | http://dx.doi.org/10.1007/s00277-023-05479-w |
Keywords | Acute and chronic GVHD; AlloHSCT; ATG Grafalon |
Attached files | |
Description | Since 2006, combined graft-versus-host disease (GVHD) prophylaxis with ATG Grafalon has been our department's base of peri-transplant supportive care. This recent retrospective study included 398 patients who underwent their first allogeneic hematopoietic stem cell transplantation after receiving a defined dose of ATG Grafalon. Our observations recorded reduced incidence of severe acute and chronic GVHD without negative impact on overall survival in a nonselected group with standard and uniform GVHD prophylaxis. |
Related projects: |